Publications & Presentations

40+ Years of Research in AI, Drug Discovery & Computational Chemistry

Search Publications & Presentations

Try kinase, pharmacophore, neural network, protein structure, ADMET, mobile, or a year such as 1992.

No papers or presentations match your search. Try a different keyword or clear the search.

Research Impact

Steven M. Muskal, Ph.D., has been Chief Executive Officer of Eidogen-Sertanty, Inc. since June 2003. He holds a Ph.D. in Chemistry from the University of California, Berkeley, and publishes on pharmacophore methods, kinase activity modeling and machine learning applied to drug discovery. He is not a medical doctor.

40+
Years of Research
20+
Peer-Reviewed Papers
1,712
Total Citations
13
h-index
30+
Conference Presentations

Citation count and h-index read from Google Scholar on 6 September 2026. Both move over time; the profiles below are the live record.

Google Scholar profile ORCID 0000-0002-3487-270X GitHub

Conference Presentations & Talks

AI for Everyone
SHK Alumni Town Hall - August 1, 2026

A projection-ready story-deck on everyday AI use while the field is still being developed: a personal, practical talk about moving from fear to fluency, and from spectacle to a tool we share with everyone. The talk connects early neural-network work, Sung-Hou Kim lab culture, AI-Steve, Food Health, Content Makes Kings, and the responsibility to help the next generation use AI well. The companion essay is on Substack and Medium.

AI for Everyone video ▶

Other Presentations

Building a business with and without scientific computing: The five W's and one H
San Diego ACS - March 14, 2016
New strategies to engage more of the world with scientific app development and content deployment
San Francisco ACS - August 11, 2014
Standing on the Shoulders of Giants: New strategies to involve more of the world with data mining and intelligence extraction
International II-SDV Conference, Nice, France - April 14, 2014
Expanding the Reach of ChemInformatics through Mobile Computing
New Orleans ACS - April 10, 2013
Integrating proprietary and public-domain data from Kinase publications and patents from a biopharmaceutical company's perspective
Webinar - September 25, 2012
Why Future Medicines Will Need to be Discovered in the Cloud
San Francisco Bio-IT World Cloud Summit - September 13, 2012
Having a mobile app presence - necessary or nice to have
San Diego ACS - March 26, 2012
Using Structural and Receptor-Site Similarity to Generate New Matter Ideas
Denver ACS - August 30, 2011
Riding the Mobile Wave
Denver ACS - August 29, 2011
Catching the Mobile Wave
Web Publication
The Mobile Kinome
ChemAxon UGM, Budapest - May 20, 2010
Using knowledgebases of structure-activity-data, receptor-site and protein structural similarity to generate new matter ideas
ACS Washington D.C. - August 16, 2009
Using Sequence-, Structure- and Receptor-site Similarity to Generate New Matter Ideas within the Kinome
Accelrys Life Science Forums - June 2009
Using Receptor-Site and Protein Structure Similarity to Generate New Matter Ideas
UK QSAR - May 14, 2009
Using Receptor-Site Similarity to LigandCross into New Diversity
CHI Fragment-Based Techniques - April 8, 2009
Exercising receptor-site similarity: From Off-Target Identification to Scaffold Hopping
ACS - August 17, 2008
Surveying ligand- and target-based similarities within the Kinome
ACS - August 17, 2008
Interrogating the Druggable Proteome: Target-Fishing and Drug Design
Beijing - October 23, 2008

Peer-Reviewed Publications

Recent Publications

Muskal, S. M. ORCID
bioRxiv preprint, first posted 21 September 2026; the DOI always resolves to the current version. doi: 10.64898/2026.09.15.751854. CC BY 4.0. Describes the Family Foundation Model.

Two separately fitted comparator models over one roster spanning 34 protein families, from kinases and GPCRs to proteases, ion channels and the epigenetic readers, writers and erasers. The compound preference model holds one target fixed and ranks two compounds; the target preference model holds one compound fixed and ranks two targets, from different families or from one family, with each kind measured on its own held-out comparisons. Every answer is an ordering with a prediction strength from 0.5 to 1.0, and accuracy climbs with strength: 0.71 over 65,725 held-out compound preference comparisons, and for target preference 0.75 over 8,689 comparisons between two families and 0.78 over 32,738 within one family, rising to 0.92, 0.89 and 0.91 at strength 0.70 and above. Trained on ChEMBL 37 alone, so both sets of weights are freely downloadable, and either model can be extended with a user's own measurements on their own machine, including targets added from an amino acid sequence.

Muskal, S. M.; Nicola, G. ORCID
bioRxiv preprint, posted 15 September 2026, version 1. doi: 10.64898/2026.09.09.750461.

Given one molecule, which proteins does it bind? Docking it into every characterized binding site answers directly and takes 40.5 hours on twenty cores. Instead every co-crystal ligand in the Protein Data Bank is indexed by the three-dimensional pharmacophore fingerprint it presents, predicted from flat structure by PharmCast, together with the proteins it was solved against. A query is fingerprinted in 4 milliseconds and searched against all 27,797 indexed ligands, covering 28,579 target sites, in 40 milliseconds, and only the proteins its nearest neighbors were crystallized with are docked. Across 3,000 held-out molecules, pooling the five most similar indexed ligands gives 21.1 candidate proteins and contains the known target 48.8 percent of the time at 108 seconds of docking; pooling twenty-five gives 104.5 proteins and 60.8 percent. Run cold, orforglipron returned the GLP-1 receptor ranked first and daraxonrasib returned its KRAS and cyclophilin A tri-complex fourth.

Muskal, S. M.; McGregor, M. J. ORCID
bioRxiv preprint, posted 7 September 2026, version 1. doi: 10.64898/2026.09.02.748999. CC BY 4.0. Describes PharmCast version 10.

In the reference pipeline, generating 100 conformers requires 2.82 s of the 2.86 s needed to fingerprint one catalog compound; the bit calculation requires 0.039 s. We therefore removed the conformational stage. PharmCast is a feedforward neural network that predicts all 10,549 bits of a PharmPrint ensemble fingerprint directly from a SMILES string, comparing two molecules in 0.584 ms where the conventional pipeline takes 5.71 s. Version 10 was trained on 5,887,229 molecules from a screening collection, activity-backed ChEMBL compounds and peptide loops excised from crystal structures. Evaluated on 155,648 purchasable screening collection compounds excluded from every training set, 139,700 held-out ChEMBL compounds and 13,500 reserved peptide loops, median fingerprint error, Pearson r and pairwise ranking accuracy are 0.008, 0.980 and 0.936 for screening collection chemistry; 0.016, 0.984 and 0.952 for loop peptides; and 0.027, 0.936 and 0.889 for activity-backed ChEMBL compounds, against the reference calculation's own reproducibility of 0.006 and 0.995.

Sonic Stimulation and Low Power Microwave Radiation Can Modulate Bacterial Virulence Towards Caenorhabditis elegans
Muskal, S. M., et al.
Anti-Infective Agents, 2019, 17, 150-162
High quality, small molecule-activity datasets for kinase research
Muskal, S. M., et al.
F1000Research, June 14, 2016
Lovastatin lactone may improve irritable bowel syndrome with constipation (IBS-C) by inhibiting enzymes in the archaeal methanogenesis pathway
Muskal, S. M.
F1000Research, April 8, 2016

Kinase & Drug Discovery

Kinome-wide Activity Modeling from Diverse Public High-Quality Data Sets
Muskal, S. M., et al.
J. Chem. Inf. Model. August 24, 2012
Novel Kinase Inhibitors by Reshuffling Ligand Functionalities Across the Human Kinome
Muskal, S. M., et al.
J. Chem. Inf. Model. November 5, 2012

Computational Methods & Tools

Reaction101 and Yield101: Two mobile apps for chemistry with pedagogical value
Muskal, S. M., et al.
Whitepaper (2011)
Interrogating the druggable genome with structural informatics
Muskal, S. M., et al.
Molecular Diversity (2006)
StructSorter: A Method for Continuously Updating a Comprehensive Protein Structure Alignment Database
Muskal, S. M., et al.
J. Chem. Inf. Model. 2006, 46, 1871-1876
STRUCTFAST: Protein Sequence Remote Homology Detection and Alignment Using Novel Dynamic Programming and Profile-Profile Scoring
Muskal, S. M., et al.
Proteins. 2006 64:960-967
Prospective Exploration of Synthetically Feasible, Medicinally Relevant Chemical Space
Muskal, S. M., et al.
J. Chem. Inf. Model. 2005, 45, 239-248

ADMET & Toxicity Prediction

Muskal, S. M.; Jha, S. K.; Kishore, M. P.; Tyagi, P.
J. Chem. Inf. Comput. Sci. 2003, 43, 1673-1678. doi: 10.1021/ci025585q

The consortium method: a compound's toxicity is predicted from the measured compounds it structurally resembles. Rebuilt in 2026 on the public record as ToxPred, it lands within one log unit of the measured rat oral LD50 92.1 percent of the time on the 1,336 of 2,873 held-out compounds it answered for, against 94 percent reported here.

Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure
Muskal, S. M., et al.
J. Chem. Inf. Comput. Sci. 1998, 38, 726-735

Early AI & Neural Network Research

Artificial Intelligence and Molecular Biology: Chapter 4 - Predicting Protein Structural Features With Artificial Neural Networks
Muskal, S. M.
Cambridge, MIT Press (1993)
Predicting Protein Secondary Structure Content: A Tandem Neural Network Approach
Muskal, S. M., et al.
J. Mol. Biol. (1992) 225, 713-727
Predicting surface exposure of amino acids from protein sequence
Holbrook, S. R., Muskal, S. M.
Protein Engineering vol. 3 no. 8 pp. 659-665, 1990
Prediction of the disulfide-bonding state of cysteine in proteins
Muskal, S. M., et al.
Protein Engineering vol. 3 no. 8 pp. 667-672, 1990

© 2025 Steven M. Muskal, Ph.D. | All Rights Reserved

Back to Main Page Eidogen-Sertanty Google Scholar